Your browser doesn't support javascript.
loading
Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat.
Uzunova, Veska; Wrynn, Aileen S; Kinnunen, Anu; Ceci, Melanie; Kohler, Christian; Uzunov, Doncho P.
Afiliação
  • Uzunova V; Novartis Institutes for BioMedical Research, Neuroscience Research, Novartis Pharma AG, WSJ-386.3.26, CH-4002 Basel, Switzerland.
Eur J Pharmacol ; 486(1): 31-4, 2004 Feb 13.
Article em En | MEDLINE | ID: mdl-14751405
ABSTRACT
Olfactory bulbectomy is one of the most validated models of depression. We demonstrate that bilateral removal of the olfactory bulbs in rats produced a significant decline of allopregnanolone content in a select cerebrocortical area which was reversed by chronic (3-week) treatment with three different classes of antidepressant (desipramine, fluoxetine, and sertraline, and venlafaxine). The effects of the chronic antidepressant treatments on allopregnanolone cortical content are observed at a time which typically coincides with the drug's abilities to reverse the behavioral deficits of the bulbectomy syndrome. We therefore propose that normalization of allopregnanolone cerebrocortical levels may contribute to the antidepressant-like profile of these drugs in the olfactory-bulbectomized rat model of depression.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bulbo Olfatório / Pregnanolona / Córtex Cerebral / Antidepressivos Limite: Animals Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2004 Tipo de documento: Article País de afiliação: Suíça
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bulbo Olfatório / Pregnanolona / Córtex Cerebral / Antidepressivos Limite: Animals Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2004 Tipo de documento: Article País de afiliação: Suíça
...